Connecticut
November 5, 2025
May 13, 2025: How AI is Changing the Pharma & Biotech Industry
Alan Jerusalmi, Chief Innovation Officer & Co-Founder, BioAI Health
Anna Langhorne, Global Chief Privacy Officer, Arvinas
Olivia Uitto, Partner, Goodwin
Zareh Zurabyan, VP of Commercial, Americas, SciSure
Moderated by James Neal, Principal, NetSuite Practice Lead, BDO USA
November 13, 2024: Top Considerations when Engaging a Potential Strategic Partnership
Adam Gilbert, Executive Director, External Accelerator, PRD, Pfizer
Gaylene Anderson, US Directorm, Strategic Research Relationships, Boehringer-
Ingelheim
Napoleon Alejandro, Director, Drug Development & Regulatory Strategy, Early
Phase Development Solutions, LabCorp
Sarah Solomon, Partner, Life Sciences Practice, Goodwin
Susan Sobolov, CEO, RIGImmune
Moderated by Manjula Donepudi, VP, Business Development, Evotec
May 22, 2024: Harnessing Your Investments: Doing More with Less
Marcia Moore, COO, Cardurion Therapeutics
Scott Phillips, CFO, Halda Therapeutics
Tim Siegert, COO, Allyx Therapeutics
Moderated by Josh Gillum, VP of Business Development, Evotec
November 8, 2023: Development Strategy for Preclinical to Clinical Success
Alexia Kedves, Sr Director, CSO Partner Team, Curie.Bio
Catherine Mesner, Advisor, Danforth Advisors
Jennifer Good, President & CEO, Trevi Therapeutics
Paul Miller, CSO, Artizan Biosciences
Moderated by Ramani Varanasi, Managing Director, Danforth Advisors
April 19, 2023: The Role of Executive Leadership in Building Innovation-Focused Cultures
Kat Kaiser-Bricker, CSO, Halda Therapeutics
Ranjit Bindra, CEO, Modifi Bio
Rob Berman, Co-founder, Biohaven Pharmaceuticals & Adjunct Prof of Psychiatry, Yale
Moderated by John Hallinan, CDO, Danforth Advisors
October 12, 2022: Alternative Forms of Financing
Jenn Beecham, Associate Director, Blavatnik Fund
Mary Anne Rooke, Managing Director, Angel Investor Forum
Michael Invernale, Sr Licensing Manager, UCONN & Consultant, CTNext
Randy Teel, Corporate Strategy & Bus Dev, Arvinas
Moderated by Gregg Beloff, Managing Director, Danforth Advisors
May 11, 2022: Challenges of Being a Public Company
David Wurzer, Venture Partner, Connecticut Innovations
Erika Smith, CEO, ReNetX Bio
Lisa Delfini, CFO, Trevi Therapeutics
Moderated by Gregg Beloff, Managing Director, Danforth Advisors